US38341P1021 - Common Stock
GOSSAMER BIO INC
NASDAQ:GOSS (3/28/2024, 8:13:56 PM)
After market: 1.18 0 (0%)1.18
+0.01 (+0.85%)
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company is headquartered in San Diego, California and currently employs 178 full-time employees. The company went IPO on 2019-02-08. The firm is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its product candidates include Seralutinib (GB002), GB5121 and GB7208. GB002 is an inhaled, small molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R), and c-KIT inhibitor in development for the treatment of pulmonary arterial hypertension (PAH). GB5121 is an oral, irreversible, covalent, small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK), in clinical development for the treatment of primary central nervous system lymphoma (PCNSL). GB5121 is selected based on its central nervous system, or CNS, penetration and kinase selectivity. GB7208 is an oral, small molecule, BTK inhibitor in preclinical development for the treatment of multiple sclerosis (MS). GB7208 is focused on undergoing preclinical testing.
GOSSAMER BIO INC
3013 Science Park Rd
San Diego CALIFORNIA 92121
P: 18589220718
CEO: Faheem Hasnain
Employees: 178
Website: https://www.gossamerbio.com/
GOSS stock results show that Gossamer Bio met analyst estimates for earnings per share the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gossamer Bio (NASDAQ:GOSS) just reported results for the fourth quarter of 2023...
Although extremely small enterprises can be terrifyingly risky, these micro-cap stock surprises deserve a closer look.
Here you can normally see the latest stock twits on GOSS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: